3 Results for "

DDO 3602

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "DDO 3602" in MCE Product Catalog:

Cat. No.: HY-178496
Research Areas:  

Cancer

DDO3602 is a PARP1 HSPTAC (HSP90-mediated proteolysis-targeting chimera) degrader, with a DC50 of 490.3 nM against PARP1; its Kd values for PARP1 and HSP90 are 66.5 nM and 1.64 nM, respectively. DDO3602 induces the formation of an unnatural PARP1-HSP90 ternary complex, recruits E3 ubiquitin ligase, and promotes PARP1 degradation via the ubiquitin-proteasome pathway. DDO3602 induces G2/M cell cycle arrest, DNA damage, inhibits cell migration, and exhibits antiproliferative activity in breast cancer cells. DDO3602 can be used in breast cancer-related research .
loading...
    loading...
Cat. No.: HY-179208
CAS No.: 2631575-47-6
Research Areas:  

Cancer

N-Descyclopropanecarbaldehyde Olaparib suberic acid is a ligand-linker conjugate that can be used for the synthesis of DDO3602 (HY-178496) .
loading...
    loading...
Cat. No.: HY-179203
CAS No.: 2355276-57-0
Research Areas:  

Cancer

N-Demethylonalespib is a ligand for E3 ligase. N-Demethylonalespib can be used for synthesis of DDO3602 (HY-178496) .
loading...
    loading...